A federal judge in Delaware has dismissed AstraZeneca's lawsuit challenging Medicare's new power to negotiate prices directly with drug manufacturers.
Drug price
Breaking News
- Barclays Under Fire for Financing an Oil Company $4.4 Billion to Release 7.5 Million Tonnes of Carbon Emission
- Donald Trump's Allies Plan to Erode Fed's Independence by Giving Ex-POTUS Influence Over it if He Wins Election
- Maryland Athletic Director Uses AI-Generated Recording to Frame up Principal as Revenge Over Fraud Investigation Against Him
The retail prices for prescription drugs have increased at a faster rate from the year 2006 to 2013. In 2013, the retail price hike for prescription drugs used by older people in America was 9.4%.
Pfizer and other pharmaceutical companies still increase its drugs price in U.S. despite criticism. Mounting objection from politicans and lawmakers is unable to stop market power of companies in the multi-billion dollar phamaceutical industry.
Subscribe to VCpost newsletter
Most Popular
- Walgreens to Open a New Pharmacy Offering Cell and Gene Therapies to Patients With Chronic Diseases Like Cancer
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Walmart Founder's Son Rob Walton to Step Down From Board
- JPMorgan CEO Warns of Economic Risks Amid Biden's 'Huge' Deficit Spending, Questions Likelihood of 'Soft Landing'
- US Secretary of State Antony Blinken Calls on China to Treat American Companies Fairly During Visit to Shanghai
